Process Validation in Pharma: 3 Stages of the FDA Lifecycle Approach
Process validation shows that a manufacturing process consistently delivers product that meets its quality requirements. The FDA's 2011 guidance, Process Validation: General Principles and Practices, treats it as a lifecycle activity with three stages: Process Design, Process Qualification, and Continued Process Verification (CPV). This article explains each stage, the records behind it, and the problems teams meet in practice.
What Is Process Validation in Pharmaceutical Manufacturing?
Process validation is the collection and evaluation of data from process design through commercial production. It provides scientific evidence that a manufacturing process can consistently deliver products that meet their predefined quality requirements.
It is important to distinguish qualification from validation. Qualification demonstrates that facilities, utilities, and equipment are suitable for their intended use. Process validation goes further by providing documented evidence that the manufacturing process, operating with qualified systems and established controls, can consistently produce products that meet predefined quality requirements.
Why Is Process Validation Important in Pharma?
Finished-product testing alone cannot guarantee consistent product quality. Pharmaceutical manufacturers must establish controlled manufacturing procedures and appropriate in-process controls to reduce variability and prevent quality failures.
In the United States, CGMP requirements for finished drug products include 21 CFR 211.100, which requires written production and process control procedures, and 21 CFR 211.110, which addresses in-process sampling and testing. These are binding regulations. The FDA's 2011 Process Validation guidance, on the other hand, provides nonbinding recommendations for implementing a science- and risk-based lifecycle approach.
Understanding the FDA's Three-Stage Lifecycle Approach
The stages run in sequence, but later data feeds back into earlier decisions.
Stage 1 – Process Design
Process Design defines the commercial manufacturing process using knowledge from development and scale-up. Teams set the process steps, identify variables, and build a control strategy to carry into manufacturing
Understanding Process Variables and Critical Quality Attributes
A critical quality attribute (CQA) is a physical, chemical, biological, or microbiological property that must stay within limits to ensure product quality. A Critical Process Parameter (CPP) is a process variable whose variation affects a CQA, so it must be monitored or controlled.
Consider a tablet manufacturing line as an illustrative example. Content uniformity and dissolution may be identified as Critical Quality Attributes (CQAs). Blend time and compression force may be potential Critical Process Parameters (CPPs), depending on process understanding and evidence of their impact on product quality.
Risk assessments and design of experiments can help teams understand these relationships and determine which process variables require monitoring or control.Type your paragraph here
Stage 2 – Process Qualification
Process Qualification evaluates whether the process design is capable of reproducible commercial manufacturing. According to the FDA lifecycle approach, Stage 2 includes two elements:
- Facility design: Along with qualification of equipment and utilities.
- Process Performance Qualification (PPQ): Demonstrates that the commercial manufacturing process performs as expected.
Facility, utility, and equipment qualification establish the foundation for PPQ. However, qualifying these systems alone does not demonstrate that the manufacturing process is capable of consistently producing quality products.
Qualification of Facilities, Utilities and Equipment
Before PPQ begins, the relevant facilities, utilities, and equipment should be appropriately qualified. This may include HVAC systems, compressed gases, and manufacturing equipment, depending on the process.
Qualification activities provide documented evidence that these systems are installed and operate as intended. Activities may include Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), as applicable.
These activities establish the foundation for PPQ by confirming that the systems supporting manufacturing are suitable for their intended use.
Process Performance Qualification (PPQ)
Process Performance Qualification (PPQ) is the second element of Stage 2. It combines qualified facilities, utilities, and equipment with trained personnel, approved procedures, and the commercial manufacturing process to demonstrate that the process performs as expected.
A typical PPQ activity involves:
Prepare the PPQ protocol
Define manufacturing conditions, operating parameters, sampling plans, testing requirements, and acceptance criteria.
Execute commercial-scale batches
Manufacture batches under normal operating conditions using trained personnel and approved procedures.
Collect and evaluate data
Review in-process results, finished-product testing, deviations, and process performance against predefined criteria.
Prepare the PPQ report
Summarise the results, assess deviations and document whether the process demonstrates reproducible performance.
The number of PPQ batches should be justified using process understanding, manufacturing complexity, variability, and the evidence needed to demonstrate reproducible performance. The FDA guidance does not prescribe a universal number of batches.
Successful completion of Stage 2 is necessary before commercial distribution under the FDA lifecycle approach. The decision should be supported by documented commercial-scale data and quality unit review.
Getting Ready for Process Qualification?
Make sure your facilities, utilities, and equipment are ready. Explore how IncepBio can support your CQV requirements.
Explore CQV ServicesStage 3 – Continued Process Verification
CPV is an ongoing program that collects and analyses product and process data to confirm the process remains in a state of control.
Monitoring Process Performance and Product Quality
During Continued Process Verification, teams regularly collect and analyse relevant process and product data to confirm that the manufacturing process remains in a state of control.
Monitoring may include Critical Process Parameters (CPPs), Critical Quality Attributes (CQAs), in-process test results, production yields, deviations and other relevant quality indicators.
The CPV programme should also define how frequently data will be reviewed, how trends will be assessed and who is responsible for investigating unexpected variations.
For example, if the fill volume on a vial production line gradually moves towards its acceptance limit, trend analysis can help identify the shift before it results in a batch failure. Teams can investigate the cause, implement corrective actions, and use change control to assess whether additional qualification or validation activities are needed.
CPV is therefore an ongoing activity throughout routine commercial manufacturing.
Key Documents Required for Pharmaceutical Process Validation
Process validation requires documented evidence to support decisions at every stage of the lifecycle. Although the FDA guidance does not prescribe a universal list of document titles, manufacturers typically maintain records that demonstrate process understanding, qualification, PPQ results, and continued monitoring.
Common documents include:
- Validation master plan or process validation plan
- Process development and technology transfer reports
- Risk assessments and the control strategy
- Equipment, utility, and facility qualification reports
- Validated analytical method records
- PPQ protocol and report
- Batch records and deviation reports
- CPV plan and periodic trend reports
- Change control records
Common Challenges in Process Validation
Even when a validation programme follows a defined lifecycle, practical gaps in process understanding, documentation, and coordination can affect its effectiveness. Some common challenges include:
Weak process understanding
Unjustified CPPs make PPQ ranges hard to defend.
Premature PPQ
Batches start before equipment or utility qualification closes.
Fixed-batch thinking
Teams may rely on a standard number of batches without scientifically justifying the number based on process understanding and variability.
Fragmented CPV data
Results sit in separate systems, which makes trending slow.
Disconnected change control
Changes happen without a validation impact assessment.
Want to Know More About CQV?
Explore the key steps involved in pharmaceutical commissioning, qualification, and validation.
Read Our CQV GuideHow CQV Supports Pharmaceutical Process Validation
Commissioning, Qualification and Validation (CQV) activities support process validation by establishing that facilities, utilities and equipment are suitable for their intended use.
Commissioning verifies that systems are installed and function as intended. Qualification provides documented evidence that they meet predefined requirements. These activities support the readiness of manufacturing systems before PPQ begins.
However, CQV activities do not replace process validation. PPQ and Continued Process Verification provide the evidence needed to demonstrate and maintain consistent process performance.
A coordinated, risk-based CQV approach helps engineering, manufacturing and quality teams plan qualification activities, manage documentation and maintain the qualified state.
Need Support with Your CQV Project?
Let’s discuss your pharmaceutical validation and qualification requirements.
Talk to Our TeamConclusion
The FDA lifecycle approach treats process validation as continuous evidence rather than a one-time batch exercise. Process design builds understanding, process qualification confirms it at a commercial scale, and continued process verification keeps the process in control. Each stage depends on sound qualification of facilities, utilities, and equipment, which is why CQV and process validation need joint planning from the start.
Frequently Asked Questions
What are the three stages of process validation?
The FDA lifecycle approach includes process design, process qualification, and continued process verification. These stages establish the process, confirm its performance through PPQ, and monitor it during routine production.
Is process validation mandatory?
Yes, CGMP regulations under 21 CFR Part 211 require manufacturers to establish and maintain controlled manufacturing processes. The FDA's 2011 guidance is nonbinding and describes recommended approaches to meeting these requirements.
How many PPQ batches are required?
The FDA does not prescribe a fixed number of PPQ batches. Manufacturers must scientifically justify the number based on process understanding, complexity, variability, and the evidence needed to demonstrate reproducible performance.
How many PPQ batches are required?
The FDA does not prescribe a fixed number of PPQ batches. Manufacturers must scientifically justify the number based on process understanding, complexity, variability, and the evidence needed to demonstrate reproducible performance.
What is the difference between qualification and process validation?
Qualification confirms that equipment, utilities, and facilities are suitable for their intended use, while process validation demonstrates that the manufacturing process consistently produces quality products. Qualification supports process validation but does not replace it.